| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 27.581.465 $ | 98,73 | 280.162 | ||||||
| GUARDANT HEALTH INC | GUARDANT HEALTH INC COM | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 2.539.558 $ | 9,09 | 16.927 | |
| NATERA INC | NATERA INC COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 2.084.465 $ | 7,46 | 7.679 | |
| KRYSTAL BIOTECH INC | KRYSTAL BIOTECH INC COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 1.768.034 $ | 6,33 | 4.757 | |
| LIGAND PHARMACEUTICALS INC | LIGAND PHARMACEUTICALS INC COM NEW | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 1.291.228 $ | 4,62 | 4.085 | |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADAPTIVE BIOTECHNOLOGIES CORP COM | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 1.114.456 $ | 3,99 | 51.956 | |
| UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 980.170 $ | 3,51 | 1.809 | |
| BRIDGEBIO PHARMA INC | BRIDGEBIO PHARMA INC COM | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 977.848 $ | 3,50 | 13.129 | |
| ELI LILLY & COMPANY | ELI LILLY & COMPANY COM | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 825.208 $ | 2,95 | 688 | |
| TWIST BIOSCIENCE CORP | TWIST BIOSCIENCE CORP COM | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 795.880 $ | 2,85 | 7.736 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 767.448 $ | 2,75 | 1.545 | |
| ASTRAZENECA PLC | ASTRAZENECA PLC ORD USD0.25 | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 754.498 $ | 2,70 | 3.979 | |
| TRAVERE THERAPEUTICS INC | TRAVERE THERAPEUTICS INC COM | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 724.498 $ | 2,59 | 12.753 | |
| INSMED INC | INSMED INC COM PAR $.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 681.089 $ | 2,44 | 6.388 | |
| SAMSUNG BIOLOGICS CO LTD | SAMSUNG BIOLOGICS CO LTD KRW2500 | EC | KR7207940008 | Long | Börsenkurs (Stufe 1) | 630.273 $ | 2,26 | 702 | |
| CORTEVA INC | CORTEVA INC COM | EC | 22052L104 | Long | Börsenkurs (Stufe 1) | 629.670 $ | 2,25 | 7.435 | |
| MEDPACE HOLDINGS INC | MEDPACE HOLDINGS INC COM | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 600.025 $ | 2,15 | 1.133 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 546.670 $ | 1,96 | 1.816 | |
| TEMPUS AI INC | TEMPUS AI INC CL A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 544.368 $ | 1,95 | 9.397 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUTICALS INC COM | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 534.335 $ | 1,91 | 6.739 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 515.380 $ | 1,84 | 3.058 | |
| REGENERON PHARMACEUTICALS INC | REGENERON PHARMACEUTICALS INC COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 501.950 $ | 1,80 | 805 | |
| VERACYTE INC | VERACYTE INC COM | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 459.210 $ | 1,64 | 7.819 | |
| ARGENX SE | ARGENX SE EUR0.10 | EC | NL0010832176 | Long | Börsenkurs (Stufe 1) | 458.271 $ | 1,64 | 494 | |
| PTC THERAPEUTICS INC | PTC THERAPEUTICS INC COM | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 408.584 $ | 1,46 | 5.009 | |
| BIONTECH SE | BIONTECH SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 386.716 $ | 1,38 | 4.156 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC COM | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 371.339 $ | 1,33 | 11.349 | |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | CHARLES RIVER LABORATORIES INTERNATIONAL INC COM | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 352.885 $ | 1,26 | 1.556 | |
| GRAIL INC | GRAIL INC COM | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 304.211 $ | 1,09 | 4.456 | |
| ANAPTYSBIO INC | ANAPTYSBIO INC COM | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 289.575 $ | 1,04 | 4.290 | |
| CRISPR THERAPEUTICS AG | CRISPR THERAPEUTICS AG NAMEN AKT | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 274.336 $ | 0,98 | 5.030 | |
| REPLIGEN CORP | REPLIGEN CORP COM | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 274.108 $ | 0,98 | 2.009 | |
| CADENCE DESIGN SYSTEMS INC | CADENCE DESIGN SYSTEMS INC COM | EC | 127387108 | Long | Börsenkurs (Stufe 1) | 272.107 $ | 0,97 | 725 | |
| BEAM THERAPEUTICS INC | BEAM THERAPEUTICS INC COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 260.043 $ | 0,93 | 7.577 | |
| PRAXIS PRECISION MEDICINES INC | PRAXIS PRECISION MEDICINES INC COM NEW | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 240.379 $ | 0,86 | 718 | |
| SARTORIUS AG | SARTORIUS AG NON VTG PFD NPV | EP | DE0007165631 | Long | Börsenkurs (Stufe 1) | 237.564 $ | 0,85 | 905 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 229.105 $ | 0,82 | 936 | |
| CAREDX INC | CAREDX INC COM | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 228.000 $ | 0,82 | 8.000 | |
| JAZZ PHARMACEUTICALS PLC | JAZZ PHARMACEUTICALS PLC SHS USD | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 218.078 $ | 0,78 | 905 | |
| CATALYST PHARMACEUTICALS INC | CATALYST PHARMACEUTICALS INC COM | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 215.767 $ | 0,77 | 6.865 | |
| THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC COM | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 211.073 $ | 0,76 | 421 | |
| IQVIA HOLDINGS INC | IQVIA HOLDINGS INC COM | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 209.064 $ | 0,75 | 1.082 | |
| HINGE HEALTH INC | HINGE HEALTH INC CL A | EC | 433313103 | Long | Börsenkurs (Stufe 1) | 194.967 $ | 0,70 | 2.349 | |
| ULTRAGENYX PHARMACEUTICAL INC | ULTRAGENYX PHARMACEUTICAL INC COM | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 171.324 $ | 0,61 | 5.131 | |
| AGILENT TECHNOLOGIES INC | AGILENT TECHNOLOGIES INC COM | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 162.451 $ | 0,58 | 1.223 | |
| DANAHER CORP | DANAHER CORP COM | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 160.384 $ | 0,57 | 842 | |
| QIAGEN NV | QIAGEN NV ORD SHARES | EC | NL0015002SN0 | Long | Börsenkurs (Stufe 1) | 133.683 $ | 0,48 | 3.419 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEUTICALS INC COM | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 116.359 $ | 0,42 | 1.048 | |
| ARCUTIS BIOTHERAPEUTICS INC | ARCUTIS BIOTHERAPEUTICS INC COM | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 115.945 $ | 0,42 | 4.422 | |
| SAMSUNG EPIS HOLDINGS CO LTD | SAMSUNG EPIS HOLDINGS CO LTD KRW2500 | EC | KR70126Z0002 | Long | Börsenkurs (Stufe 1) | 104.357 $ | 0,37 | 376 | |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC ORD SHS CL A | EC | GB00BRXB0C07 | Long | Börsenkurs (Stufe 1) | 94.582 $ | 0,34 | 1.479 | |
| TARSUS PHARMACEUTICALS INC | TARSUS PHARMACEUTICALS INC COM | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 71.500 $ | 0,26 | 1.136 | |
| BIO-RAD LABORATORIES INC | BIO-RAD LABORATORIES INC CL A | EC | 090572207 | Long | Börsenkurs (Stufe 1) | 71.347 $ | 0,26 | 243 | |
| LIQUIDIA CORP | LIQUIDIA CORP COM NEW | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 69.445 $ | 0,25 | 871 | |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY COM | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 68.914 $ | 0,25 | 1.196 | |
| TG THERAPEUTICS INC | TG THERAPEUTICS INC COM | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 68.840 $ | 0,25 | 1.253 | |
| BEONE MEDICINES LTD | BEONE MEDICINES LTD SPONSORED ADS | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 64.118 $ | 0,23 | 225 | |
| NEUROGENE INC | NEUROGENE INC COM | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 62.302 $ | 0,22 | 1.981 | |
| FIRST TRACKS BIOTHERAPEUTICS INC | FIRST TRACKS BIOTHERAPEUTICS INC ORD SHS | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 55.833 $ | 0,20 | 2.775 | |
| GENEDX HOLDINGS CORP | GENEDX HOLDINGS CORP COM CL A | EC | 81663L200 | Long | Börsenkurs (Stufe 1) | 39.474 $ | 0,14 | 575 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENCES LTD SHS | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 27.964 $ | 0,10 | 4.813 | |
| RECURSION PHARMACEUTICALS INC | RECURSION PHARMACEUTICALS INC CL A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 20.211 $ | 0,07 | 5.507 | |
| OMNIAB INC | OMNIAB INC USD0.0001 A (USD15 VESTING) | EC | 68218J301 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 480 | |
| Gesamt | 27.581.465 $ | 98,73 | 280.162 |